|
⚲
|
| Keyboard |
| Sawhney Roger
✚
|
|
|---|---|
| CIK # | 0001858748 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001858748] | |
| 4 | [0001858748] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sawhney Roger | |
| Arbutus Biopharma Corp | |
| Actuate Therapeutics Inc | |
| Alimera Sciences Inc | |
| Omega Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2025-08-04 | Grant | 157,600 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Non-Qualified Stock Options · derivative
|
2024-08-12 | Grant | 30,000 | $0.00 | |
|
Alimera Sciences Inc ALIM
Stock Option (Right to Buy) · derivative
|
2023-02-25 | Grant | 2,252 | $0.00 | |
|
Omega Therapeutics Inc OMGA
Option (Right to Buy) · derivative
|
2022-03-09 | Grant | 60,000 | $0.00 | |
|
Omega Therapeutics Inc OMGA
Common Stock
|
2021-08-03 | Buy | 2,941 | $17.00 | 49,997 |